NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.

Ryu D, Zhang H, Ropelle ER, Sorrentino V, Mázala DA, Mouchiroud L, Marshall PL, Campbell MD, Ali AS, Knowels GM, Bellemin S, Iyer SR, Wang X, Gariani K, Sauve AA, Cantó...

21 ottobre 2016

Caloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding.

De Andrade PB, Neff LA, Strosova MK, Arsenijevic D, Patthey-Vuadens O, Scapozza L, Montani JP, Ruegg UT, Dulloo AG, Dorchies OM. OM.Front Physiol. 2015 Sep 16;6:254

07 ottobre 2016

Santhera Starts Phase III Study (SIDEROS) with Raxone in Patients with Duchenne Muscular Dystrophy Using Glucocorticoids

28 settembre 2016

New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases.

Hruska-Plochan M, Li B, Kyburz D, Krützfeld J, Landmesser U, Aguzzi A, Polymenidou M. Swiss Med Wkly. 2015 Sep 16;145:w14192.

16 settembre 2016

Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing.

Odermatt P, Trüb J, Furrer L, Fricker R, Marti A, Schümperli D. Mol Ther. 2016 Aug 30.

13 settembre 2016

Current and future therapeutic approaches to the congenital myopathies.

Jungbluth H, Ochala J, Treves S, Gautel M. Semin Cell Dev Biol. 2016 Aug 8.

08 settembre 2016

Santhera erhält FDA-Förderbeitrag zur Unterstützung der laufenden Phase-I-Studie mit Omigapil bei kongenitaler Muskeldystrophie

Press release August 30th, 2016

30 agosto 2016

Loss of fibronectin from the aged stem cell niche affects the regenerative capacity of skeletal muscle in mice.

Lukjanenko L, Jung MJ, Hegde N, Perruisseau-Carrier C, Migliavacca E,... Feige JN, Bentzinger CF. Nat Med. 2016 Jul 4. [Epub ahead of print]

15 luglio 2016

Force training induces changes in human muscle membrane properties.

Z'Graggen WJ, Trautmann JP, Bostock H. Muscle Nerve. 2016 Jun;54(1):144-6.

04 luglio 2016

Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.

Herrendorff R, Faleschini MT, Stiefvater A, Erne B, Wiktorowicz T, Kern F, Hamburger M, Potterat O, Kinter J, Sinnreich M. J Biol Chem. 2016 Jun 13. [Epub ahead of...

27 giugno 2016